Immunocore Holdings (IMCR) Non-Current Debt (2020 - 2026)

Immunocore Holdings has disclosed Non-Current Debt across 7 years of filings, most recently posting $393.7 million for Q1 2026.

• Non-Current Debt for Q1 2026 came in at $393.7 million, up 0.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $393.7 million (up 0.54% YoY), and the FY2025 annual result was $393.1 million, up 0.54% from the prior year.
• Non-Current Debt came in at $393.7 million for Q1 2026 at Immunocore Holdings, roughly flat from $393.1 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $438.1 million in Q2 2024 to a low of $46.3 million in Q4 2022.
• The 5-year median for Non-Current Debt is $392.1 million (2025), against an average of $337.7 million.
• Across the five-year window, Non-Current Debt jumped 714.42% in 2024 and declined 10.52% in 2025, its largest moves.
• Immunocore Holdings' Non-Current Debt stood at $46.3 million in 2022, then rose by 3.63% to $48.0 million in 2023, then surged by 714.42% to $391.0 million in 2024, then grew by 0.54% to $393.1 million in 2025, then rose by 0.14% to $393.7 million in 2026.
• The last three Non-Current Debt figures came in at $393.7 million (Q1 2026), $393.1 million (Q4 2025), and $392.6 million (Q3 2025), per Business Quant data.